PIVOT-12: a phase III study of adjuvant bempegaldesleukin plus nivolumab in resected stage III/IV melanoma at high risk for recurrence

Alexander Mm Eggermont, Paolo A. Ascierto, Nikhil I. Khushalani, Dirk Schadendorf, Genevieve Boland, Jeffrey Weber, Karl D. Lewis, Daniel Johnson, Gareth Rivalland, Adnan Khattak, Margarita Majem, Helen Gogas, Georgina V. Long, Sue L. Currie, David Chien, Mary A. Tagliaferri, Matteo S. Carlino, Adi Diab

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'PIVOT-12: a phase III study of adjuvant bempegaldesleukin plus nivolumab in resected stage III/IV melanoma at high risk for recurrence'. Together they form a unique fingerprint.

Medicine & Life Sciences